Glenn HearsonJan 2, 2021Published StudyBenralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
Glenn HearsonNov 17, 2020Recruiting StudyAPEX Asthma Exacerbation Studies NewsletterOur APEX research studies looking into asthma attacks (exacerbations) new newsletter is now available. The APEX Studies are investigating...
Glenn HearsonNov 9, 2020Latest ResearchPONENTE study hits the mark in phase IIIb asthma trialPONENTE Phase IIIb open-label Fasenra (benralizumab)
Glenn HearsonOct 5, 2020Published StudyOutcome of Hospitalization for COVID-19 in Patients with Interstitial Lung DiseaseOutcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study
Glenn HearsonOct 5, 2020Recruiting StudyThe Nottingham Recovery from COVID-19 Research Platform Assessment ClinicThe Nottingham Recovery from COVID-19 Research Platform Assessment Clinic
Glenn HearsonAug 14, 2020NewsWhat would it take to get you involved in research? Take our SurveyWhat would it take to get you involved in research? Take our Survey
Glenn HearsonAug 1, 2020COVID-19Dexamethasone in Hospitalized Patients with Covid-19 Preliminary ReportDexamethasone in Hospitalized Patients with Covid-19 Preliminary Report
Glenn HearsonJul 30, 2020Latest ResearchSummer 2020 Asthma Newsletter Including Synairgen COVID-19 drug Trial success and Patient StorySummer 2020 Asthma Newsletter Including Synairgen COVID-19 drug Trial success and Patient Story